Changes of glucocorticoid receptor mRNA expression in basolateral amygdale-kindled rats

Chinese Medical Journal

Volumn 124, Issue 17, 2011, Pages 2622-2627

  Bao, Guan Shui ^a   Cheng, Xu Qin ^b   Hua, Yin ^c   Wang, Zhe Dong ^b   Liu, Zhen Guo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Anti epilepsy drugs; Basolateral amygdala; Epilepsy; Glucocorticoid receptor; Kindling

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; MESSENGER RNA; TOPIRAMATE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT THERAPY; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; GENE EXPRESSION REGULATION; GENE FUNCTION; GLUCOCORTICOID RECEPTOR GENE; HIPPOCAMPUS; KINDLING; MALE; NEUROPATHOLOGY; NONHUMAN; RAT; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE;

AMYGDALA; ANIMALS; EPILEPSY; KINDLING, NEUROLOGIC; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80052552487     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.17.011     Document Type: Article

References (48)

1. Besedovsky H, Sorkin E. Network of immuneneuroendocrine interactions. Clin Exp Immunol 1977; 27: 1-12.
2. Cintra A, Bhatnagar M, Chadi G, Tinner B, Lindberg J, Gustafsson JA, et al. Glial and neuronal glucocorticoid receptor immunoreactive cell populations in developing, adult, and aging brain. Ann N Y Acad Sci 1994; 746: 42-63.
3. Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, et al. Maternal care, hippocampal glucocorticoidreceptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997; 277: 1659-1662.
4. Wright AP, Zilliacus J, McEwan IJ, Dahlman-Wright K, Almlof T, Carlstedt-Duke J, et al. Structure and function of the glucocorticoid receptor. J Steroid Biochem Mol Biol 1993; 47: 11-19.
5. Mattews HR FRA, Miesfeld RL. Biochemistry: A Short Course. Willey-Liss, Inc.; 1998: 247-326.
6. Kitraki E, Karandrea D, Kittas C. Long-lasting effects of stress on glucocorticoid receptor gene expression in the rat brain. Neuroendocrinology 1999; 69: 331-338.
7. Han JS, Bizon JL, Chun HJ, Maus CE, Gallagher M. Decreased glucocorticoid receptor mRNA and dysfunction of HPA axis in rats after removal of the cholinergic innervation to hippocampus. Eur J Neurosci 2002; 16: 1399-1404.
8. Dahlqvist P, Zhao L, Johansson IM, Mattsson B, Johansson BB, Seckl JR, et al. Environmental enrichment alters nerve growth factor-induced gene A and glucocorticoid receptor messenger RNA expression after middle cerebral artery occlusion in rats. Neuroscience 1999; 93: 527-535.
9. Quan N, Avitsur R, Stark JL, He L, Shah M, Caligiuri M, et al. Social stress increases the susceptibility to endotoxic shock. J Neuroimmunol 2001; 115: 36-45.
10. Kerr DS, Campbell LW, Thibault O, Landfield PW. Hippocampal glucocorticoid receptor activation enhances voltage-dependent Ca2+ conductances: relevance to brain aging. Proc Natl Acad Sci U S A 1992; 89: 8527-8531.
11. Xu J, Chen S, Chen H, Xiao Q, Hsu CY, Michael D, et al. STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes. J Neurosci 2009; 29: 2022-2026.
12. Ildan F, Polat S, Oner A, Isbir T, Cetinalp E, Kaya M, et al. The effect of the treatment of high-dose methylprednisolone on Na(+)-K(+)/Mg(+2) ATPase activity and lipid peroxidation and ultrastructural findings following cerebral contusion in rat. Surg Neurol 1995; 44: 573-580.
13. Capasso A, Sorrentino L, Di GA, Palazzesi S, Pieretti S, Loizzo A. Dexamethasone and hormones related to the hypothalamic-pituitary-adrenal axis modulate inherited neocortical spindling in DBA/2J mice. Neuropsychobiology 1994; 29: 143-151.
14. Ben-Menachem E, Sander JW, Stefan H, Schwalen S, Schauble B. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy. Clin Ther 2008; 30: 1180-1195.
15. Edmonds HL Jr, Jiang YD, Zhang PY, Shank R. Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegeneration. Life Sci 2001; 69: 2265-2277.
16. Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004; 187: 403-409.
17. Kaminski RM, Tochman AM, Dekundy A, Turski WA, Czuczwar SJ. Ethosuximide and valproate display high efficacy against lindane-induced seizures in mice. Toxicol Lett 2004; 154: 55-60.
18. Marson AG, Williamson PR, Clough H, Hutton JL, Chadwick DW. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002; 43: 505-513.
19. Paxinos G, Watson C. The rat brain in stereotaxic coordinates.San Diego: Elsevier Academic Press; 2005.
20. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972; 32: 281-294.
21. Tritos N, Kitraki E, Philippidis H, Stylianopoulou F. Neurotransmitter modulation of glucocorticoid receptor mRNA levels in the rat hippocampus. Neuroendocrinology 1999; 69: 324-330.
22. Galvis-Alonso OY, Cortes De Oliveira JA, Garcia-Cairasco N. Limbic epileptogenicity, cell loss and axonal reorganization induced by audiogenic and amygdala kindling in wistar audiogenic rats (WAR strain). Neuroscience 2004; 125: 787-802.
23. Fenoglio-Simeone K, Mazarati A, Sefidvash-Hockley S, Shin D, Wilke J, Milligan H, et al. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon. Epilepsy Behav 2009; 16: 52-57.
24. Long JJ, Ma J, Leung LS. Behavioral depression induced by an amygdala seizure and the opioid fentanyl was mediated through the nucleus accumbens. Epilepsia 2009; 50: 1953-1961.
25. Escalante-Membrillo C, Paz C. Development of an experimental model of epilepsy in rats exposed to ozone. Toxicol Lett 1997; 93: 103-107.
26. Ullal GR, Satishchandra P, Kalladka D, Rajashekar K, Archana K, Mahadevan A, et al. Kindling & mossy fibre sprouting in the rat hippocampus following hot water induced hyperthermic seizures. Indian J Med Res 2006; 124: 331-342.
27. Watzka M, Bidlingmaier F, Beyenburg S, Henke RT, Clusmann H, Elger CE, et al. Corticosteroid receptor mRNA expression in the brains of patients with epilepsy. Steroids 2000; 65: 895-901.
28. Hwang IK, Lee YB, Yoo KY, Kang TC, Kim DW, Moon WK, et al. Seizure-induced changes of mineralocorticoid and glucocorticoid receptors in the hippocampus in seizure sensitive gerbils. Neurosci Res 2005; 53: 14-24.
29. Nyakas C, De Kloet ER, Veldhuis HD, Bohus B. Hippocampal corticosterone receptors and novelty-induced behavioral activity: effect of kainic acid lesion in the hippocampus. Brain Res 1983; 288: 219-228.
30. Lowy MT. Kainic acid-induced decrease in hippocampal corticosteroid receptors. J Neurochem 1992; 58: 1561-1568.
31. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci U S A 2009; 106: 3543-3548.
32. Kumar G, Couper A, O'Brien TJ, Salzberg MR, Jones NC, Rees SM, et al. The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology 2007; 32: 834-842.
33. Meaney MJ, Aitken DH, van BC, Bhatnagar S, Sapolsky RM. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988; 239: 766-768.
34. McCullers DL, Sullivan PG, Scheff SW, Herman JP. Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat. Neuroscience 2002; 109: 219-230.
35. Abraham I, Harkany T, Horvath KM, Veenema AH, Penke B, Nyakas C, et al. Chronic corticosterone administration dose-dependently modulates Abeta(1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol 2000; 12: 486-494.
36. Reagan LP, McEwen BS. Controversies surrounding glucocorticoid-mediated cell death in the hippocampus. J Chem Neuroanat 1997; 13: 149-167.
37. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19: 269-301.
38. Pitkanen A. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models. Epilepsy Res 2002; 50: 141-160.
39. Wauquier A, Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res 1996; 24: 73-77.
40. Yehuda R, Yang RK, Golier JA, Tischler L, Liong B, Decker K. Effect of topiramate on glucocorticoid receptor mediated action. Neuropsychopharmacology 2004; 29: 433-439.
41. Reis J, Tergau F, Hamer HM, Muller HH, Knake S, Fritsch B, et al. Topiramate selectively decreases intracortical excitability in human motor cortex. Epilepsia 2002; 43: 1149-1156.
42. Qian J, Noebels JL. Topiramate alters excitatory synaptic transmission in mouse hippocampus. Epilepsy Res 2003; 55: 225-233.
43. Ogg MS, Williams JM, Tarbit M, Goldfarb PS, Gray TJ, Gibson GG. A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro. Xenobiotica 1999; 29: 269-279.
44. Usui T, Saitoh Y, Komada F. Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. Biol Pharm Bull 2003; 26: 510-517.
45. Oscarson M, Zanger UM, Rifki OF, Klein K, Eichelbaum M, Meyer UA. Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther 2006; 80: 440-456.
46. Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Tetich M, Kubera M, Leskiewicz M, et al. Mood stabilizers inhibit glucocorticoid receptor function in LMCAT cells. Eur J Pharmacol 2004; 495: 103-110.
47. Zhou R, Gray NA, Yuan P, Li X, Chen J, Chen G, et al. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J Neurosci 2005; 25: 4493-4502.
48. Leskiewicz M, Budziszewska B, Lason W. Endocrine effects of antiepileptic drugs. Przegl Lek 2008; 65: 795-798.